RxDoctor Payments Data

Kyle Hornsby, MD

Clinical Cardiac Electrophysiology · Bloomington, INNPI 1184868838

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Abbott at 38.6% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.

$13,224in general payments, 2019–2025

Across 195 payments — averaging $67.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Medtronic$3K
  • Boston Scientific$2K
  • Medical Device Business Services, Inc.$2K
  • Biosense Webster, Inc.$548
  • Johnson & Johnson$324
  • plus $1K from 11 others

What the payments were for

  • Travel & lodging$7,26255%
  • Food & beverage$5,92345%
  • Education$400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,224 in reported general payments places this provider in the 45th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$237,796
Medicare patients
1,662
Services billed
3,843

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban507$497,064
XareltoRivaroxaban136$126,026
EntrestoSacubitril/Valsartan61$74,305
MultaqDronedarone Hcl15$22,833
Flecainide Acetate94$4,164
Metoprolol Succinate272$3,577
Diltiazem 24hr Er (Cd)Diltiazem Hcl105$2,624
Diltiazem 24hr Er (La)Diltiazem Hcl23$1,994
Atorvastatin Calcium185$1,916
Digoxin26$1,826
Dabigatran EtexilateDabigatran Etexilate Mesylate13$1,815
Warfarin Sodium96$1,073
Rosuvastatin Calcium55$833
Carvedilol83$791
Amiodarone Hcl97$777

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$65$497,064507 claims
Johnson & JohnsonXarelto$324$126,026136 claims
NovartisEntresto$121$74,30561 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

Other clinical cardiac electrophysiology in Bloomington

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →